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Computational De Novo Design and Characterization of a Protein That Selectively
Binds a Highly Hyperpolarizable Abiological Chromophore
Abstract
This work reports the first example of a single-chain protein computationally designed to contain four αhelical segments and fold to form a four-helix bundle encapsulating a supramolecular abiological
chromophore that possesses exceptional nonlinear optical properties. The 109-residue protein,
designated SCRPZ-1, binds and disperses an insoluble hyperpolarizable chromophore, ruthenium(II) [5-(4'ethynyl-(2,2';6',2″-terpyridinyl))-10,20-bis(phenyl)porphinato]zinc(II)-(2,2';6',2″-terpyridine)(2+) (RuPZn) in
aqueous buffer solution at a 1:1 stoichiometry. A 1:1 binding stoichiometry of the holoprotein is
supported by electronic absorption and circular dichroism spectra, as well as equilibrium analytical
ultracentrifugation and size exclusion chromatography. SCRPZ-1 readily dimerizes at micromolar
concentrations, and an empirical redesign of the protein exterior produced a stable monomeric protein,
SCRPZ-2, that also displayed a 1:1 protein:cofactor stoichiometry. For both proteins in aqueous buffer, the
encapsulated cofactor displays photophysical properties resembling those exhibited by the dilute RuPZn
cofactor in organic solvent: femtosecond, nanosecond, and microsecond time scale pump-probe
transient absorption spectroscopic data evince intensely absorbing holoprotein excited states having
large spectral bandwidth that penetrate deep in the near-infrared energy regime; the holoprotein
electronically excited triplet state exhibits a microsecond time scale lifetime characteristic of the RuPZn
chromophore. Hyper-Rayleigh light scattering measurements carried out at an incident irradiation
wavelength of 1340 nm for these holoproteins demonstrate an exceptional dynamic hyperpolarizabilty
(β1340 = 3100 × 10(-30) esu). X-ray reflectivity measurements establish that this de novo-designed
hyperpolarizable protein can be covalently attached with high surface density to a silicon surface without
loss of the cofactor, indicating that these assemblies provide a new approach to bioinspired materials
that have unique electro-optic functionality.
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Abstract
This work reports the first example of a single-chain protein computationally designed to contain
four α-helical segments and fold to form a 4-helix bundle encapsulating a supramolecular
abiological chromophore that possesses exceptional nonlinear optical properties. The 109-residue
protein designated SCRPZ-1, binds and disperses an insoluble hyperpolarizable chromophore,
ruthenium(II) [5-(4′-ethynyl-(2,2′;6′,2″-terpyridinyl))-10,20-bis(phenyl)porphinato]zinc(II)-(2,2′;
6′,2″-terpyridine)2+ (RuPZn) in aqueous buffer solution at a 1:1 stoichiometry. A 1:1 binding
stoichiometry of the holoprotein is supported by electronic absorption and CD spectra, as well as
equilibrium analytical ultracentrifugation and size exclusion chromatography. SCRPZ-1 readily
dimerizes at μM concentrations, and an empirical redesign of the protein exterior produced a
stable monomeric protein, SCRPZ-2, that also displayed a 1:1 protein:cofactor stoichiometry. For
both proteins in aqueous buffer, the encapsulated cofactor displays photophysical properties
resembling those exhibited by the dilute RuPZn cofactor in organic solvent: femtosecond-,
nanosecond-, and microsecond-timescale pump-probe transient absorption spectroscopic data
evince intensely absorbing holoprotein excited states having large spectral bandwidth that
penetrate deep in the near-infrared (NIR) energy regime; the holoprotein electronically excited
triplet state exhibits a microsecond timescale lifetime characteristic of the RuPZn chromophore.
Hyper-Rayleigh light scattering (HRS) measurements carried out at an incident irradiation
wavelength (λinc) of 1340 nm for these holoproteins demonstrate an exceptional dynamic
hyperpolarizabilty (β1340 = 3100 × 10−30 esu). X-ray reflectivity measurements establish that this
de novo designed hyperpolarizable protein can be covalently attached with high surface density to
a silicon surface without loss of the cofactor, indicating that these assemblies provide a new
approach to bio-inspired materials that have unique electro-optic functionality.
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Introduction
Natural cofactors confer function to biological proteins that cannot be achieved with the
amino acids alone. Examples of such functions include transduction of light energy, oxygen
binding, and enzymatic catalysis. Natural cofactors include metal atoms, metal clusters,
flavins, quinones, and metalloporphyrins. Synthetic proteins provide the potential to
incorporate nonbiological cofactors that can confer new functionalities not seen in nature.
For many cofactor-binding proteins, non-covalent interactions play a critical role in
positioning the cofactor within the protein matrix. Computational protein design engineers
these noncovalent interactions, and can now create systems capable of incorporating
synthetic nonbiological cofactors, thereby yielding peptide-based systems with novel
functionalities.1–5 Importantly, the interior of the designed protein scaffold can be used to
control cofactor conformation, solubility, location, and orientation, as well as the cofactor
local molecular and dielectric environment, thus providing multiple mechanisms by which
to modulate cofactor properties, facilitate the nature of their organization with identical and
dissimilar proteins, and target their placement at surfaces and interfaces. To realize protein
complexes that possess novel functions through specific binding of large non-natural
cofactors, computational protein design is critical.
Chromophores that feature extended π-electron systems and electronic asymmetry can
exhibit exceptionally large molecular hyperpolarizabilities;6–22 incorporation of such an
abiological cofactor into a de novo designed protein provides a strategy to define a protein
having unique electro-optic function. Dipolar, “push-pull” chromophores that have desirable
nonlinear optical (NLO) functionality often exploit a conjugated bridge to couple integral
donor and acceptor elements. One striking example is ruthenium(II) [5-(4′-ethynyl-(2,2′;6′,
2″-terpyridinyl))-10,20-bis(phenyl)porphinato]zinc(II)-(2,2′;6′,2″-terpyridine)2+ (RuPZn,
Chart 1),13,14 a hyperpolarizable supermolecular chromophore that features highly
conjugated (porphinato)metal and poly(pyridyl)metal components. In RuPZn and related
supermolecules, (porphinato)zinc π-π*- and metal polypyridyl-based charge-resonance
absorption oscillator strength are extensively mixed, and the respective charge transfer
transition dipoles of these building blocks are aligned along the highly conjugated molecular
axis. These structures manifest significant inter-pigment electronic interactions, display
unusual dependences of the sign and magnitude of the hyperpolarizability upon incident
irradiation frequency, and exhibit extraordinarily large dynamic hyperpolarizability βλ
values at long wavelengths (1.3–1.55 μm).13,14,18–20,23–26 RuPZn, for example, possesses
an exceptional βλ value at an incident irradiation wavelength of 1300 nm (β1300 = 5100 ×
10−30 esu).13
The development of macroscopic materials that possess impressive nonlinear properties
based on these chromophores requires control and ordering of hyperpolarizable molecules in
a non-centrosymmetric arrangement throughout the medium. For dipolar molecules
dispersed randomly within the solid state, ground-state electrostatic interactions drive
detrimental, centrosymmetric aggregation that diminishes the macroscopic electro-optic
response. Although experimental strategies exist that minimize the magnitude of antiparallel
dipole-dipole interactions of NLO chromophores in the condensed phase, such as electricfield poling of chromophoric guests within polymeric hosts, it is important to underscore
that the net bulk-phase dipolar order realized in such NLO materials rarely, if ever, exceeds
a level beyond that of several percent of the chromophoric dopants present in the
medium.27–34
As proteins bind and control the conformation and orientation of cofactors, modulate their
functional properties, and encode for protein-protein organization over mesoscopic and
macroscopic length-scales, de novo proteins offer new opportunities to control NLO
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functional elements. In this report, we demonstrate that (i) computational protein design can
be utilized to realize a single-chain protein with four α-helical segments that folds to bind
and encapsulate the supermolecular RuPZn chromophore, and show that (ii) this de novo
protein manifests photophysical and electro-optical properties characteristic of its RuPZn
cofactor, and (iii) that a variant of this protein having appropriate C-terminal functionality
provides a self-assembled, ordered monolayer of this novel functional protein-cofactor
complex on silicon at high-density surface coverage, while preserving its classic NLO
response. Taken together, these results illustrate a practicable approach towards designing
protein-based electro-optic devices.

Methods
Computational Design of Protein Structure
The single-chain four-helix bundle protein was designed using previously described
computationally guided methods for backbone construction, loop selection, and side-chain
placement.1,3,4 A tetrameric helix bundle backbone was constructed to accommodate the
cofactor and contained a hydrogen-bonded His-Thr pair, where the His axially coordinates
the central Zn(II) ion of the porphyrin macrocycle (Figure 1).4 Bundle construction resulted
in a tetramer of antiparallel 24-residue alpha helices (Figure 2A). Loops connecting these
helices were selected from a database of natural alpha helical protein structures and were
spliced so as to not conflict sterically with the remainder of the structure (Figure 2B).1 The
loops were positioned so as to minimize root mean square differences (rmsd) between the
respective Cα atoms of the loop termini and the Cα atoms of the helix termini (Figure 2).1
Within the resulting 109-residue structure, residues were relaxed via energy minimization
using CHARMM35 and the steepest decent method for 15 steps. Bond lengths and angles
were checked using PROCHECK.36 As discussed in previous work,1,3,4 the cofactor was
positioned so as to achieve axial Zn(II) coordination via the predetermined His residue, and
the internal torsion about the ethyne bridge was selected so that the angle between the planes
of the porphryin and the bridged terpyridyl moiety is commensurate with the superhelical
twist of the four-helix bundle.
Protein Design: Sequence SCRPZ-1
Computational methods guided the selection of the protein sequence. In the design
calculations, the tertiary structure and presence of the RuPZn cofactor are present as
described above. In addition, the residues involved in Zn(II) coordination of the cofactor,
His45 and its hydrogen-bonded partner Thr8, were constrained to have these identities as
well as side chain conformations consistent with Zn(II) coordination.1,3,4 A statisticallyguided, computationally assisted design strategy was applied that utilizes a self-consistent
approach to estimate site-specific probabilities of the amino acids at variable positions as
discussed previously.1,4 Protein design was carried out in two rounds of computational
design calculations.2,37
In the first calculation, all amino acids were allowed at the 106 variable positions except for
Cys, His, and Pro: Cys and His were precluded to prevent untargeted Zn(II) coordination
and disulfide formation; Pro, a known helix breaker, was allowed only in the loop regions at
residues where it is present in the template loops. The residue identities were selected to be
the most probable amino acids whose probability p1 satisfies p1≥0.3: LEU2, GLY9, ILE12,
ALA16, VAL19, GLU21, LEU31, LEU34, ALA38, ALA49, ASN56, GLU57, GLN63,
GLY64, ILE67, ALA71, VAL74, LEU78, GLU82, LEU86, ALA93, LEU103, LYS107.
(Numbering of residues is chosen such that the first residue is denoted MET0, which was
appended to the N-terminus of the designed sequence.) Many of these positions are within
the interior of the protein structure. Residues in the loop regions are solvent exposed and

J Am Chem Soc. Author manuscript; available in PMC 2014 September 18.

Fry et al.

Page 4

multiple amino acids are probable at most positions. Positions 26 and 81 adopt an alpha-left
configuration, and these were specified to be Gly (GLY26, GLY81), which is consistent
with the Schellman αL-β turn of these loop regions.38 Previous studies of turns near alpha
helices also identified a preference for Asp at positions 29 and 84 in these turns: ASP29,
ASP84. Residue 27 has a structure similar to that of GLU82, and its identity was specified
as GLU27. The following residues were constrained to have the identities present in the
template loops, identities that are also among the probable amino acids at each site: SER30,
LEU48, TYR50, ASN51, ARG52, MET53, GLY54, ALA55, THR58, ALU59, GLY81,
ASP84, SER85.
After fixing the identities discussed above, the probabilities of the amino acids at the
remaining positions were determined using a second calculation. The following are the most
probable amino acid identities in their respective positions: GLU1, GLU3, LYS4, LEU5,
ARG6, GLN7, GLU10, GLN11, GLN14, ILE15, LYS17, GLN18, ILE22, MET23, LYS25,
GLU32, LEU35, LYS36, TYR39, ILE42, GLN44, GLN47, ILE60, LYS62, GLN66,
GLU69, GLN73, ASN75, GLU76, LYS80, GLU87, GLN88, ILE90, LYS91, ILE97,
GLN99, GLN101, GLU102, GLU105, LYS106, and ASN108. Probable hydrophobic amino
acids were selected at residues near the cofactor or at helix-helix interfaces: LEU13, LEU37,
LEU41, ALA56, MET61, LEU68, ILE70, VAL77, LEU89, LEU92, LEU96, LEU100, and
PHE104. Positions 27 and 82 in were specified as the probable ASP (ASP27, ASP82), and
previous work suggests a large propensity for the amino acid at this position in the turn.38
Positions 24 and 79 were specified as LEU, the identity in the template loop, which is
among the probable amino acids (LEU24, LEU79). The following amino acids were
selected from among the probable amino acids to foster potential hydrogen bonding and saltbridge interactions observed in the modeled protein: GLN33, GLU40, GLN43, THR47,
GLU53, GLU54, ASP57, GLN65, GLN72, LYS83, TYR94, GLN95, GLN98. Due to its
proximity to the cofactor, a small hydrophobic amino acid was selected from among the
probable amino acids at position 56: ALA56. The resulting protein is denoted SCRPZ-1:
MELEKLRQTG EQILQIAKQV NEIMLKGDDD SLEQLIKLAY ELIQQHTQLA
YNRQEAADTE IMKQGQQILE IAQQVNEVLL KGDKDSLEQL LKLAYQLIQQ
LQELFEKKN.
Empirical Redesign: Sequence SCRPZ-2
To explore control of oligomerization state in the absence of co-solvents and the robustness
of the folding and binding properties of the protein with respect to mutation, we chose to
redesign the protein exterior. SCRPZ-1 has a neutral charge and exterior hydrophobic
patches (Figure S2). Using the SCRPZ-1 structure and sequence, the exterior of the protein
was redesigned with the intent of increasing the number of ionizable residues on the protein
exterior, while incorporating interhelical salt bridges to ensure bundle stability. The model
structure of SCRPZ-1 was aligned with a similarly designed protein, PASC, a 109-residue
protein that is a monomer under similar conditions (Figure S1).1 For this alignment, ten
sequential residues beginning 5 residues away from the αLβ (GD) turn from each helix were
selected. Overall, 40 residues were aligned and found to have a 1.33 Å rmsd (Figure S1).
Eleven exterior residues were mutated to the corresponding exterior amino acid in PASC:
Q11E, K17Q, N20R, L24D, L37E, Q44K, E69Q, N75R, L79D, L92E, and Q99K (Figure
3A). Two other positions, L24 and L79 appeared in the loop template and were modified to
charged residues consistent with the PASC design. Upon inspection of the structure, N20R,
L37E, N75R, and L92E appeared to be good candidates from which to engineer salt-bridged
pairs: N20R-K91E; L37E-N18R; N75RK36E; and L92E-Q73R (Figure 3B). The following
modifications were made to generate ionic pairs spanning a hydrophobic patch that resulted
from complementary cofactor and interhelical, hydrophobic packing of SCRPZ-1: E10DQ101R and T46R-Q65D (Figure 3C). The resulting protein, SCRPZ-2, possesses 19
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mutations relative to SCRPZ-1. The redesigned protein presents a more charged exterior, as
well as interhelical salt bridges that span a hydrophobic patch (Figure S2). The resulting
protein is denoted SCRPZ-2: MELEKLRQTG DEILQIAQRV REIMDKGDDD
SLEQLLEEAY ELIQKHRQLA YNRQEAADTE IMKQGDQILQ IAQRVREVLD
KGDKDSLEQL IEEAYQLIQK LRELFEKKN.
SCRPZ-1, SCRPZ-2, and SCRPZ-3 Gene Construction and Expression
Each synthetic gene (DNA 2.0 for SCRPZ-1 and Genscript for SCRPZ-2) were preceded by
the NdeI and terminated by the HindIII restriction sites and codon optimized for expression
in E. coli. The genes were successfully ligated to the NdeI/HindIII digested pET24a+
expression vector (which contains the IPTG-inducible T7 promoter) using T4 ligase
following the manual protocol. Gene amplification with pfu polymerase was performed
using standard T7 promoter and T7 terminator DNA primers and sequencing of the
amplified product allowed the identification of the successfully ligated gene into the pET24a
+ expression vector (University of Pennsylvania sequencing center). See Supporting
Information (SI) for the gene sequences used to express the proteins SCRPZ-1 and
SCRPZ-2.
The synthetic gene designed to express a C-terminus (Gly)3Cys sequence to enable surface
immobilization via coupling chemistry was constructed via PCR amplification utilizing taq
polymerase and the following primers: (SCRPZ_3 Promoter) GCAG CAT ATG GAA CTG
GAA AAA CTG CGT CA and (SCRPZ_3 Terminator) GCAG AAG CTT TTA ACA TCC
GCC TCC GTT TTT CTT TTC GAA CA. The resulting product was then double digested
using the NdeI and HindIII restriction enzymes in order to remove the nonsense GCAG
sequence. Agarose gel electrophoresis was used to purify the digested gene insert. The gene
was then inserted into the pET 24a+ expression vector followed by gene amplification and
sequencing to confirm insertion as described previously. See SI for the gene sequence that
expresses the protein SCRPZ-3: MELEKLRQTG EQILQIAKQV NEIMLKGDDD
SLEQLIKLAY ELIQQHTQLA YNRQEAADTE IMKQGQQILE IAQQVNEVLL
KGDKDSLEQL LKLAYQLIQQ LQELFEKKN GGGC.
The proteins were expressed using BL21(DE3) cells. The cells were grown to an optical
density at 600 nm between 0.6 and 0.9 prior to induction with 1mM IPTG. After 3 h, the
cells were centrifuged (20 m, 4000 g, 4 °C) and the LB supernatant was decanted. The
resulting pellet was resuspended in DPBS (30mL) and the cells were lysed by sonication.
Following centrifugation (30 m, 15 000 g, 4 °C), the supernatant was heat-denatured at 70
°C followed by centrifugation (30 m, 15 000 g, 4 °C). The protein remained in the
supernatant as visualized by gel electrophoresis (MES SDS PAGE) and was lyophilized.
The crude material obtained from the expression was reconstituted in Millipore purified
water at a concentration of 6 mg/mL for purification by reversed phase HPLC (Varian
ProStar) over a C4 column (Vydac). Collection of the major peak and analysis by MALDITOF MS (PerSeptive Biosystems Voyager DE) indicated correct mass spectral data
(SCRPZ-1 calc’d 12708.5, found, 12710.0; SCRPZ-2 calc’d, 12943.6, found, 12944.0;
SCRPZ-3 calc’d, 12982.8, found, 12983.2). Once the protein was purified and thoroughly
lyophilized, it was reconstituted in buffer (50 mM phosphate, 150 mM NaCl, pH 7.5)
typically to a concentration of 200–300 μM, and used immediately.
Cofactor ‘Reconstitution’; Holoprotein Preparation
Samples were prepared by diluting a concentrated stock solution into 50 mM phosphate
buffer with 150 mM sodium chloride and pH 7.5. A two-fold excess of the cofactor RuPZn
(see SI for synthetic scheme)13 was added from a 5 mM DMSO stock solution (note: final
DMSO concentration in buffer was kept below 1%). The sample was heated to >50 °C for
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15 m followed by cooling to room temperature. Any unbound cofactor would visibly
aggregate and was removed via spin filtration (Millipore Ultrafree MC 0.22 μm). To remove
DMSO, chromatography with a NAP5 or PD10 (GE Healthcare) gravity column
equilibrated with the desired buffer as eluent was sufficient. Amicon centrifugal devices
were used when necessary to concentrate the pre-purified samples to desired concentrations.
Samples were made typically at RuPZn concentrations ranging from 25 – 100 μM.
Electronic Absorption and Circular Dichroism (CD) Spectroscopy
Electronic absorption spectral data were obtained on a Hewlett Packard 8453
spectrophotometer at room temperature in a 1-cm quartz cuvette. To evaluate the secondary
structure and stability of the protein and the complex, CD spectroscopy was carried out at 25
°C on a Jasco 810 Spectropolarimeter in 0.1-cm cuvettes. Buffer conditions for CD
experiments were 50 mM phosphate buffer, 150 mM sodium chloride, pH 7.5; the protein
concentration was 25–50 μM. Samples were pre-purified with either NAP5 or PD10 gravity
columns to remove excess cofactor and DMSO, as the organic solvent absorbs light in the
190 – 260 nm scanning region of the spectrum. For thermal denaturation experiments, the
ellipticity at 222 nm was monitored as a function of temperature. Data were collected every
2 °C with a heating rate of 1 °C/min followed by a 4-min equilibration time.
To determine the peptide:cofactor stoichiometry, titration experiments were performed. 300
μL of a solution of 17.5 μM RuPZn was prepared in 50 mM phosphate buffer, containing
150 mM sodium chloride, pH 7.5, and 1% (w/v) octylgucopyranoside (OG). (The surfactant
OG is necessary for cofactor solubilization). 2.0 μL aliquots of 320 μM SCRPZ-1 were
introduced into the solution and allowed to equilibrate for 5 min before each spectrum was
obtained. RuPZn binding was monitored spectrophotometrically at 660 nm as the protein
was titrated into the cofactor solution. A similar procedure using the same buffer conditions
was followed for analyzing SCRPZ-2 binding: to 300 μL of 8 μM RuPZn was added 2.0 μL
aliquots of 113 μM SCRPZ-2.
Size Exclusion Chromatography
Gel filtration profiles were obtained using a Superdex 75 10/300GL column on an FPLC
system (GE Healthcare AKTA FPLC System). To evaluate the oligomeric state, 100 μL of a
20 μM sample was injected onto the column and eluted with a 50 mM phosphate buffer, 150
mM NaCl, pH 7.5 mobile phase at a flow rate of 0.5 mL/min. In cases where aggregation
was suspected, 5% isopropanol was added to the elution buffer in an attempt to break up
aggregates. Approximation of the molecular weight (MWapp) was calculated from a
standard curve obtained using the mass standards blue dextran, Ve (void volume): aprotinin,
6500 Da; cytochrome c, 12 400 Da; carbonic anhydrase, 29 000 Da; and albumin, 66 000
Da.
Analytical Ultracentrifugation: Sedimentation Equilibrium
For analytical ultracentrifugation, 125 μL samples of 160 μM apo-protein and 20 μM holoprotein in 50 mM phosphate buffer and 150 mM NaCl at pH 7.5 were prepared. The samples
were filtered prior to analysis using a 0.22 μm spin filter. Analysis was performed at 25 °C
using a Beckman XL-I analytical ultracentrifuge. The absorbance was monitored at 280 nm
for apo-protein and 430 nm for holo-protein, and the samples were centrifuged at 20 000, 25
000, and 30 000 rpm. The data were analyzed using a modified global fitting routine in
IGOR Pro (Wavemetric) and assumed a single molecular weight species. The protein
maintains its calculated partial specific volume when the monomeric molecular weight is
held constant. The partial specific volume (ν) of 0.735 mL/g and solvent density (ρ) of 1.01
g/mL was calculated using SEDNTERP.
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Pump-probe transient absorption spectroscopy
Nanosecond transient absorption spectra were recorded with a previously described Qswitched Nd:YAG laser system (DCR-1A, Quanta Ray, Mountain View, CA).39 Samples
were prepared at concentrations of 10 μM in 50 mM phosphate 150 mM NaCl buffer at pH
7.5 followed by three freeze (−40 °C)/pump/thaw cycles in a 1 cm Quartz cuvette. The
monoexponential triplet state lifetime data were analyzed using a single exponential decay
model in the program Origin 7.5.
Picosecond transient absorption spectra were acquired using standard pump-probe methods.
A schematic of this transient optical system, as well as a detailed description of the
apparatus, have been described previously.14 Probe light was generated using an allreflective optics configuration. Polarization of the pump beam was set at the magic angle by
a Rochon polarizer; polarization of the probe light was set using a waveplate and a rotating
sapphire plate to obtain horizontal polarization. The polarization of the probe beam was
confirmed using crossed polarizers. All these experiments utilized 1 mm-path-length fusedsilica sample cells. Samples were all prepared between 75 and 125 μM in 50 mM phosphate,
150 mM NaCl buffer at pH 7.5. The samples were deoxygenated via three consecutive
freeze (−5 or −40 °C)/pump/thaw cycles or a 30 min argon purge. All transient spectra
reported represent averages obtained over at least 3 scans with each scan consisting of 150–
250 time points.
Hyper Rayleigh Light Scattering (HRS) Measurements
Femtosecond HRS experiments were performed at 800, 1300 and 1340 nm.40,41 Disperse
red 1 (DR1; β1300 = 54 × 10−30 esu; β1340 = 50 × 10−30 esu)41 in CHCl3 was utilized as a
reference chromophore. For these external references in different solvents, standard local
, where n is the refractive index of the
field correction factors were applied [
solvent (chloroform, 1.4459; water, 1.333) at the sodium D line]. Note that these
experiments were performed at low (μM) holoprotein (chromophore) concentrations where
the linearity of the HRS signal as a function of protein (chromophore) concentration
confirmed that no significant self-absorption of the SHG signal occurred in these
experiments. For HRS experiments carried out at an irradiation wavelength of 800 nm,
crystal violet (CV) in methanol solvent was utilized as a chromophoric reference (β800 = 338
× 10−30 esu). Note that in these experiments, the difference in molecular symmetry
(octopolar for CV, dipolar for RuPZn) has been taken into account.40 The samples were
prepared as described above. To ensure that the observed HRS signal at the secondharmonic wavelength is purely second-order scattering, and not due to multiphoton
fluorescence, frequency-resolved femtosecond HRS experiments were performed. These
measurements show neither a demodulation nor an increase in phase delay with increasing
amplitude modulation, indicating the absence of any multiphoton fluorescence contribution
to the observed HRS signals. This finding is in line with the results reported earlier for other
members of this class of (polypyridyl)ruthenium-(porphinato)zinc(II) chromophores.13,26
SCRPZ-3 Immobilization on Silicon Substrates
The reducing agent, 1,4-dithiothreitol (DTT) was purchased from Acros Organics (Morris
Plains, NJ). The silane used for alkylation, 3-aminopropyldimethylethoxysilane, was
obtained from Gelest Inc. (Morrisville, PA). The linker, succinimidyl 4-[N-maleidomethyl]cyclohexane-1-carboxylate (SMCC), as well as other solvents and reagents used for selfassembly, were obtained from Fisher Scientific (Springfield, NJ). All purchased chemicals
were used without further purification. The fused silica slides (UV grade; 25 mm × 70 mm)
were bought from Esco Products (Oak Ridge, NJ) and the 3″ diameter silicon wafers (n-type

J Am Chem Soc. Author manuscript; available in PMC 2014 September 18.

Fry et al.

Page 8

Si:P – 600 μm thick) were purchased from El-Cat Inc. (Waldwick, NJ). In order to increase
the sensitivity and spatial resolution of the x-ray reflectivity technique by employing an
interferometric approach, multilayers comprised of 50 Å Si – 20 A Ge – 20 Å Si – 20 Å Ge
– 20 Å Si were deposited sequentially onto the silicon wafers via magnetron sputtering. This
fabrication was performed in the deposition laboratory at the Advanced Photon Source
(APS) at Argonne National Laboratory (ANL) (Argonne, IL).
The silicon wafers with the multilayer structure were cut into pieces of 20 mm × 10 mm
dimension suitable for x-ray experiments, while the fused silica slides were cut into pieces
of 25 mm × 35 mm dimension suitable for linear UV/visible absorption spectroscopy. Both
the silicon wafer slides and fused silica slides were treated together, from cleaning through
monolayer deposition. The slides were cleaned using methanol, chloroform, and acetone
through sonication in each of these solvents for 10 min. Later the slides were alkylated with
3-aminopropyldimethylethoxysilane under an Ar atmosphere by immersing the substrates in
a 5% silane solution in toluene for 1 hour. The slides were rinsed with toluene and sonicated
in this solvent for 10 min. The slides were cured subsequently under Ar at 67 °C for 1 h. For
linker attachment, the slides were placed in 1mM SMCC solution in anhydrous methanol for
1 h, following which they were rinsed with methanol, sonicated for 10 min, and dried using
a jet of Ar gas.
SCRPZ-3 possesses a C-terminal cysteine to facilitate the covalent attachment of the peptide
bundle to a suitably alkylated surface of an inorganic substrate. SCRPZ-3 incorporating the
RuPZn chromophore was first treated with DTT in 1:1 mole ratio, for 10 min at room
temperature, to remove possible disulfide linked peptides. Subsequent dialysis against
potassium phosphate buffer (100 mM at pH 7) for 3 h at room temperature was employed to
remove DTT from the protein solution. For covalent attachment, slides possessing the
SMCC linker on their surface were incubated in a SCRPZ-3 solution (50 μM protein in 100
mM potassium phosphate buffer at pH 8) at 4 °C overnight to allow covalent bond
formation between the SMCC linker and the C-terminal cysteine. The protein-monolayerfunctionalized substrates were then washed several times with flowing ultra-pure water
(Millipore, Billerica, MA) in order to remove nonspecifically adsorbed molecules. The
substrates were then stored under Ar at 4 °C prior to experimental measurements.
X-ray Reflectivity and Linear Electronic Absorption Spectroscopy
The x-ray reflectivity (XR) data for the covalently-attached monolayer films on silicon
substrates having a multilayer structure were collected using a triple-axis diffractometer with
an Enraf-Nonius F-591 rotating-anode x-ray source and a scintillation detector. A curved
LiF crystal was utilized to select and collimate the Cu-Kα1 spectral line. Further collimation
was achieved by the slits before and after the specimen chamber, with the resolution
determined by the analyzer crystal before the scintillation detector. Reflectivity data were
recorded over the range of photon momentum transfer Qz from 0.01 to 0.52 Å−1. At lower
incident angles, the x-ray beam was attenuated by nickel foils inserted upstream from the
specimen. The specimen chamber with Kapton windows was maintained at 24 °C. A LI-610
dewpoint generator (LI-COR, Lincoln, NE) was additionally fitted to maintain the relative
humidity inside the chamber in excess of 96% in helium. Linear electronic absorption
spectroscopic data were collected at room temperature from the self-assembled monolayer
films on fused silica substrates using a Lambda 650 spectrophotometer (PerkinElmer
Waltham, MA).
The raw x-ray reflectivity data from the covalently-attached monolayer films were
normalized by the Fresnel function, using the software C-Plot (Certified Scientific Software,
Cambridge, MA), to eliminate the effects due to dynamical scattering from a single ideal
interface, leaving the kinematical scattering due to the presence of the multilayer reference
J Am Chem Soc. Author manuscript; available in PMC 2014 September 18.

Fry et al.

Page 9

structure with the attached self-assembled monolayer on its surface. Subsequent analysis
was performed using the Distorted Wave Born Approximation and the so-called boxrefinement algorithm,42 implemented via Mathematica 4.2 (Wolfram Research, Champaign,
IL), for solving the phase problem and obtaining the electron-density profile that fully
accounts for the observed reflectivity data. This approach has been thoroughly described in
prior publications43,44 for covalently-attached monolayer films on multilayer reference
structures. The linear electronic absorption spectroscopic data were used to confirm that the
RuPZn chromophore remained bound to the SCRPZ-3 via axial histidyl ligation of its
(porphinato)zinc moiety even after immobilization on to the solid substrate and subsequent
washing.

Results and Discussion
Computationally designed tetra-α-helical proteins are capable of preferentially binding
synthetic, abiological (porphinato)metal chromophores.1,3–5 For example: 1) a D2symmetric homotetramer bundle capable of binding two (5,15-di[(4carboxymethyleneoxy)phenyl]porphinato)iron [(DPP)Fe] cofactors,3 2) a D2-symmetric
homotetramer bundle capable of binding four (DPP)Fe units,5 3) a C2-symmetric
heterotetramer bundle capable of binding two light-activatable (DPP)Zn chromophores,4 and
4) an asymmetric, single-chain tetrahelical bundle capable of binding two (DPP)Fe species,1
have all been successfully designed and characterized. These designed proteins
preferentially bind and target nonbiological cofactors even in the presence of naturally
occurring protoporphyrin IX complexes bearing the same metal ion. Likewise, a de novo
tetrahelical bundle has been designed that binds both a Ru(bpy)2 (bpy = 2,2′ bipyridyl) unit
and a heme cofactor through independent bishistidine axial coordination at a separate sites,
defining an artificial reaction center protein.45 In sum, this body of work indicates the
selectivity in cofactor recognition achievable with carefully designed proteins.
Cofactor Design
RuPZn (Chart 1), a chromophore closely related to a structure established to possess an
exceedingly large hyperpolarizability at telecommunications-relevant wavelengths,13,14,18
was designed and synthesized to facilitate incorporation into a designed protein. The
cofactor was synthesized using methods described previously, through cross-coupling a 4′
brominated bis(2,2′;6′,2″-terpyridine)ruthenium complex with [5-ethynyl-10,20-bisphenylporphinato] zinc(II). Note that the only difference between RuPZn and the parent
supermolecule upon which it is based,13,14,18 lies in the nature of the porphyrin 10- and 20aryl substituents, which lack bulky 2′,6′-bis(3,3-dimethyl-1-butyloxy) substituents, which
were anticipated to be an impediment to the formation of complementary interactions
between protein and cofactor. As these 2′,6′-bis(3,3-dimethyl-1-butyloxy) substituents lie
orthogonal to the π-conjugated framework of the chromophore, it was assumed that this
cofactor modification would not impact the RuPZn hyperpolarizability relative to the
previously established benchmark.
Design of proteins: SCRPZ-1, SCRPZ-2, SCRPZ-3
Single-chain, genetically encodable proteins were computationally designed to bind the
RuPZn cofactor. Previous work has employed synthetic amphiphilic helical bundles
comprising multiple peptide chains that bind this class of extended π-electron porphyrin
molecules, including RuPZn.23,24,46–48 The amphiphilic nature of the design allows for selfassembly at the air-water interface generating Langmuir monolayers. Our current design,
SCRPZ-1, differs in that the protein was computationally designed specifically for RuPZn
and is not simply a promiscuous binder of cofactors containing a (porphinato)zinc moiety.
This computational design was done in an attempt to enhance the binding affinity and
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structural specificity, control the chromophore-localized electrostatic environment, ensure
cofactor orientational homogeneity, and produce a more stable material.
The overall construction of the 109-residue protein began with assigning the coordination
environment around the (porphinato)zinc moiety (Figure 1). Previous related work involving
engineering a (porphinato)zinc (PZn) binding site within a de novo heterotetrameric αhelical bundle provided single histidine coordination for the metalloporphyrin moiety.4
Presentation of a side-chain conformation of HIS45 consistent with Zn coordination was
assisted by the presence on an adjacent helix containing THR8, which is positioned to
hydrogen bond to the δ-nitrogen of this histidine.1,3,4 Design calculations identified a
porphyrin-contacting leucine (LEU100) at the ‘distal’ site of the PZn moiety opposite
HIS45, in this work and in a previous study (Figure 1).4
A suitable tertiary structure was created for binding RuPZn (Figure 4). Coordinates of four
helices consistent with the cofactor structure and coordination of the central metal ion of the
unit were modeled as discussed previously.1,3,4 Three loops from an inter-helical loop
database were selected and incorporated between helices to generate a single chain
backbone as discussed previously for a similar single-chain, four-helix protein.1
The model of the tertiary structure containing the RuPZn cofactor was used in the
computational design of a sequence for the protein. Residues associated with Zn ion
coordination (HIS45, THR8) were constrained in their identities and side-chain
conformations. The remaining positions were specified using results from a method that
self-consistently estimates the site-specific probabilities of amino acids at variable positions
in the structure.1–4,37,49 The method incorporates constraints on sequence properties and
uses atomistic energy functions. The resulting designed protein, SCRPZ-1, possesses: (a) the
aforementioned Zn(II) coordinating HIS45, (b) largely hydrophobic residues within its
interior near the cofactor that form a cavity that complements the shape of the cofactor, and
(c) largely hydrophilic exterior residues (Figure 4). Note that the SCRPZ-1 holoprotein the
cofactor constitutes 8% of the total mass (SCRPZ-1 = 12708.5 g/mol, [RuPZn]2+ = 1114.2
g/mol, SCRPZ-1 holoprotein = 13822.7).
At micromolar concentrations, SCRPZ-1 dimerizes in solution, but the monomer is
preferred with the addition of isopropanol (vide infra). To arrive at a monomeric form of the
protein and probe the robustness of the designed protein’s structure and binding properties
with respect to exterior mutations, the exterior of the protein was redesigned. Select Cα
carbon atoms of the model protein backbone were aligned with the Cα carbon atoms present
in a model of the known monomeric protein PASC (Chart S1).1 With this structural
alignment as a guide, 11 residues were changed to those present at equivalent positions in
PASC. Four additional residues were modified to generate salt bridges with those residues
adopted from the PASC exterior. In addition, four more residues were modified to
incorporate two interhelical salt bridges, vide infra. The resulting protein, SCRPZ-2,
possesses 19 mutations relative to SCRPZ-1.
For surface immobilization studies of the protein, four additional C-terminal residues were
added to SCRPZ-1: GGGC (Figure 4E). The CYS112 residue in the resulting protein,
SCRPZ-3, provides a reactive residue for covalent attachment to functionalized silica
surfaces.
Electronic Absorption Spectroscopy
Electronic absorption spectra (EAS) of the cofactor in DMSO solvent and the cofactor
bound to SCRPZ-1 and SCRPZ-2 are presented in Figure 5. As expected, the spectrum of
the cofactor in DMSO is consistent with that reported previously for the parent
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supermolecule in acetonitrile solvent.13 Note that while RuPZn exhibits strong mixing of
the (porphinato)Zn(II) (PZn) based oscillator strength with metal polypyridyl chargeresonance bands (as the spectrum does not evince transitions that derive from the simple
superposition of precursor compound spectra), spectral qualities are retained that trace their
genesis to those of classical PZn and bis(terpyridyl)ruthenium(II) ([Ru(tpy)2]2+) oscillators.
RuPZn is characterized by: (i) a strong (ε > 100,000 M−1 cm−1) absorption near ~435 nm
which features significant porphyrin-derived 1π–π* Soret (B) band character; (ii) a visible
band centered at ~505 nm which exhibits significant [Ru(tpy)2]2+-derived singlet metal-toligand charge transfer (1MLCT) character and marked contributions from porphyrin ligand
oscillator strength; and (iii) bands localized at ~565 and ~640 nm which exhibit
porphyrinic 1π–π* Q-state character, with the lower energy, xpolarized transition
manifesting features due to symmetry breaking and oscillator strength redistributions that
derive from conjugation expansion8,10,50 and charge resonance character that originates
from the ethyne-bridged porphyrin meso-carbon-to-terpyridyl-carbon linkage.13,14 Note as
well that the RuPZn spectrum exhibits two prominent ultraviolet (UV) absorption bands
near 270 and 310 nm that correspond largely to terpyridine localized π–π* transitions. While
it is recognized that MLCT (d-π*), Soret (B)- and Q-band (π–π*) electronic states mix
extensively in these supermolecules,51 for the sake of simplicity, we utilize these transition
labels to denote the dominant contributor to the oscillator strength of a given transition
manifold in the discussion that follows.
When bound within the binding site of the de novo designed proteins, RuPZn exhibits shifts
spectral features relative to those observed in DMSO solvent (Figure 5). In the SCRPZ-1
holoprotein, red shifts are observed in the Soret- (445 nm), MLCT- (516 nm), and xpolarized Q band- derived (658 nm) transition manifolds. Similarly, in the SCRPZ-2
holoprotein, the RuPZn spectrum features a red-shifted, clearly split Soret manifold (440
and 459 nm), a red-shifted MLCT-derived transition (520 nm), and a lower energy and
intensified Qx-state-derived transition (662 nm). As these RuPZn spectral shifts track with
protein binding,1,3–5 these transitions can be used to monitor cofactor-protein association.
Note that while the SCRPZ-1,2 apoproteins feature absorption at 280 nm (ε ~ 3840 M−1
cm−1, due to the π–π* transitions of the three Tyr residues), the oscillator strength of this
absorbance is virtually negligible relative to that of the chromophore at this wavelength (ε >
40 000 M−1 cm−1).
Spectrophotometric titrations of protein into a solution of RuPZn (50 mM phosphate, 150
mM NaCl, pH 7.5 and 1% w/v octylglucopyranoside as a surfactant) displayed the expected
red-shift in the Q-band upon addition of the proteins (Figure 6). For both proteins, a 1:1
protein:RuPZn stoichiometry was observed, with spectral shifts saturating near one
equivalent of the protein added. For SCRPZ-2, the equivalence point is not as sharp as it is
for SCRPZ-1, suggesting a lower binding affinity. Fitting these titration data to a 1:1
equilibrium binding model52 provides dissociation constants of KD = 32 ± 1 nM for
SCRPZ-1 and KD = 1.23 ± 0.1 μM for SCRPZ-2. Note that these values represent apparent
dissociation constants in the presence the surfactant 1% w/v octylglucopyranoside, which
was required to enhance the solubility of the cofactor in order to perform the experiments;
the cofactor is not soluble in the aqueous buffer alone. Note that these data are consistent
with earlier work that examined a heterotetrameric helical protein that binds two synthetic
(porphinato)zinc chromophores (KD, avg. = 0.28 μM),4 as well as that which studied RuPZn
binding to a de novo-designed amphiphilic 4-helix bundle peptide in which simple
bis(histidyl) ligation was exploited to bind the chromophore (KD < 100 nM).23 Likewise,
other metalloporhyrins established to bind to helical bundle proteins feature experimentally
determined cofactor dissociation constants that range from <1 nM to 15 μM.53 Within our
current study, the lower RuPZn KD value obtained for SCRPZ-1 is not surprising,
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considering its rigorous computational design; in contrast, the empirical redesign of
SCRPZ-2 appears to have yielded a cofactor pocket that binds RuPZn less tightly.
Circular Dichroism Spectroscopy
Circular dichroism (CD) spectra acquired for SCRPZ-1 and SCRPZ-2 are consistent with
highly helical proteins in both their respective apo and holo forms. The spectra possess
minima at 208 and 222 nm with similar mean residue ellipticities, which are indicative of
~60% α-helical content (Figure 7). Both proteins retain these helical signatures in the
presence of the cofactor, and the spectral intensities increase slightly for SCRPZ-1 in the
presence of RuPZn, but decrease slightly for SCRPZ-2. The changes are close to
experimental error, and too small to be interpreted in terms of significant changes in
secondary structure. On the other hand in the vis-NIR region, the measured ellipticity
suggests that the two proteins offer disparate binding environments for the cofactor,
exemplified by the observed differences in the CD spectra (Cotton effect) over 400–700 nm
spectral domain (Figure 8). Thermal melt profiles of the two systems indicate substantial
helical thermostabilities of both the apo and holo forms, as no cooperative loss of helical
content is observed over the temperature range T = 0 – 98 °C (Figure 9).
Size Exclusion Chromatography
Size exclusion chromatography of 20 μM SCRPZ-1 (50 mM phosphate, 150 mM NaCl, and
pH=7.5) indicates a monodisperse, monomeric protein at the expected elution volume, Ve =
12.5 mL (Figure 10A). However, upon addition of the cofactor, higher molecular weight
oligomers were observed, with a dimer comprising the dominant species in solution (Ve =
10.7 mL). In order to test for oligomerization due to hydrophobic association, the column
was treated with 5% isopropanol (v/v), resulting in an equilibrium concentration reflecting
~80% monomer. Collection of this peak, followed by electronic absorption spectral analysis
confirmed that the cofactor remained bound to the peptide. In the case of SCRPZ-2, the apoprotein eluted as a distribution of monomeric, dimeric, and trimeric species (Ve = 9.0, 10.7,
and 12.5 mL respectively; Figure 10B). Upon addition of the cofactor, the holoprotein eluted
as ~90% monomer (Ve = 12.5 mL). Isopropanol treatment of the column was not necessary
to drive the equilibrium toward the monomer state for holo-SCRPZ-2.
Analytical Ultracentrifugation: Sedimentation Equilibrium
The oligomerization states of the designed proteins in the apo and holo forms were analyzed
via analytical ultracentrifugation (AU). Using a single molecular weight model (assuming a
monomeric protein) apo-SCRPZ-1 (160 μM) yielded an estimated MW = 21 700 ± 700 D.
As the expected (calculated) molecular weight is 12708.5 D, these data suggest oligomer
formation at this concentration (Figure 11). It is noteworthy that this AU-estimated MW
contrasts that determined for apo-SCRPZ-1 via size exclusion chromatography under similar
conditions, which indicated a monodisperse, monomeric protein; in this regard it is
important to underscore that the protein concentrations used in these AU studies exceed that
utilized for size exclusion chromatography by tenfold, and likely drives a substantial protein
dimer population under these conditions. For holo-SCRPZ-1 (20 μM), analyzing the data
using a single species (assuming a monomeric protein) yielded a MW = 28 300 ± 300 D; the
corresponding calculated molecular weight is 13 823 D. Holo-SCRPZ-1 thus appears to
favor a dimeric state under AU experimental conditions, and is consistent with size
exclusion chromatographic data (Figure 11).
AU data for SCRPZ-2 indicate predominant monomeric proteins for both the apo and holo
forms. Analysis of the apo-SCRPZ-2 ([protein] = 160 μM) data using a model that considers
only a single species yielded a MW = 13 100 ± 800 D, consistent with the expected
molecular weight of the monomer, 12942.5 D. At a concentration of 160 μM, apo-SCRPZ-2
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exists in predominantly the monomeric state. For holo-SCRPZ-2 (20 μM), AU data analysis
using a single component model yields a MW =16 500 ± 300 D, near the expected calculated
MW of 14 057 D. The slightly higher than expected value is likely due to the presence of a
minor dimeric protein population under these AU experimental conditions, resembling the
results of the size exclusion chromatographic analysis which indicated that holo-SCRPZ-2
eluted primarily (~90%) as a monomeric protein.
SCRPZ-1 and SCRPZ-2 possess the same helical backbone template structure, but differ in
19 exterior residues, which alters the oligomerization behavior. In their apo states at
concentrations of 20 μM, both SCRPZ-1 and SCRPZ-2 proteins exist predominantly in the
monomer form, which is consistent with data obtained from size-exclusion chromatography.
Upon addition of the RuPZn cofactor, SCRPZ-2 exists predominantly monomer, whereas
SCRPZ-1 displays a monomer-dimer-trimer equilibrium. SCRPZ-1 contrasts SCRPZ-2 in
that it features exterior hydrophobic patches comprising hydrophobic residues in proximity
to neutral glutamines. These hydrophobic patches may form points of contact for
dimerization, consistent with the observation that treating holo-SCRPZ-1 with isopropanol
increased the population of monomer (Figure 10).
All in all, two proteins have been designed, SCRPZ-1 and SCRPZ-2, that are capable of
binding and encapsulating a complex synthetic chromophore, RuPZn. The chromophore
itself has previously been shown to exhibit an exceptionally high hyperpolarizability, and an
unusual electronically excited triplet state. Critical transient dynamical and nonlinear optical
data that characterize the holo-SCRPZ-1,2 proteins are summarized below.
Excited-State Transient Dynamical Studies
The RuPZn chromophoric prototype has previously been studied via pump-probe
spectroscopic methods over the femtosecond through microsecond time domains.13,14,18
Excited-state relaxation dynamics of ethyne-bridged (porphinato)zinc(II)-metal(II)bis(terpyridyl)ruthenium supermolecules exhibit marked differences from those delineated
for their component chromophoric building blocks (PZn and [Ru(tpy)2]2+). Monomeric
(porphinato)zinc(II) compounds generally relax through both the singlet and triplet
manifolds, leading to deactivation on both the nanosecond (singlet) and millisecond (triplet)
timescales at room temperature.14,18 Electronically excited [Ru(tpy)2]2+ undergoes rapid
inter-system crossing to the low-lying metal-to-ligand charge transfer (triplet) surface,54–56
but then is rapidly quenched by thermally populating a low-lying metal centered (3MC) state
such that the 3MLCT lifetime at 298 K is ~250 ps.57 In RuPZn and previously reported
related compounds, transient absorption spectra obtained at early time delays (tdelay < 400
fs) demonstrate fast excited state relaxation and the characteristics of a highly polarized T1
excited state; the combined effects of rapid inter-system crossing and strong coupling to
low-lying MLCT states gives rise to excited-state lifetimes on the order of tens of
microseconds.14 Interrogation of the electronically excited states of RuPZn (data not shown)
via pump-probe transient optical methods reveals spectral features characteristic of this class
of chromophoric supermolecules that include: (i) prominent visible region bleaching due to
ground-state depletion, (ii) a broad, weak transient absorption in the spectral region between
the high oscillator strength ground-state bleaches, and (iii) an expansive, intense T1→Tn
absorption manifold that dominates the 800–1200 nm region of the NIR.14,18
Pump-probe spectroscopic studies of holo-SCRPZ-1 (50 mM phosphate buffer, 5%
isopropanol, 150 mM NaCl, pH 7.5) demonstrate transient dynamics and spectral evolution
similar to that exhibited by the cofactor in organic solvent. Figure 12 shows exemplary
transient absorption spectral data for holo-SCRPZ-1 obtained over a 0.7 picosecond (ps) –
5.5 nanosecond (ns) time domain, and highlights the multi-exponential nature of its
relaxation dynamics. A global exponential fit to these transient absorption data acquired at
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multiple wavelengths yields three time constants: τrise = 13.9 ps, τdecay = 1.8 ns, and a longlived component (τlong > 9.6 ns) that exceeds the track resolution of the instrument. The
13.9 ps component leads to an increase in the intensity of the T1→Tn NIR transient
absorption band; previous studies show that these dynamics are associated with torsional
motion about the ethynyl bridge,18,58–60 with the relaxed 3MLCT state featuring
conformeric distributions having a reduced mean torsional angle between the porphyrin and
terpyridine least-squares planes. While this relaxed excited triplet state displays augmented
T1→Tn manifold transition oscillator strength with respect to that evident in the initially
prepared 3MLCT state of closely related chromophores,18,59 the oscillator strength evolution
observed over time delays ranging from 1–50 ps for holo-SCRPZ-1 is less dramatic than
that observed for the chromophore in organic solvent, consistent with a more restricted
range of porphyrin-terpyridyl torsional angles for RuPZn in the protein matrix relative to
solution. Note that RuPZn in organic solvent does not manifest a 1.8 ns decay component.
Holo-SCRPZ-2 (50 mM phosphate buffer, 150 mM NaCl, pH 7.5), which exists
predominantly as a monomer in the absence of isopropanol, was interrogated using pumpprobe experimental conditions identical to those used for holo-SCRPZ-1. Global data fitting
shows that holo-SCRPZ-2 exhibits analogous excited-state relaxation dynamics (τrise = 12.7
ps, τdecay = 1.8 ns, and τlong > 9.6 ns; Figure 13). The fact that holo-SCRPZ-2 manifests a
1.8 ns decay component identical to that observed for holo-SCRPZ-1 in the absence of
isopropanol, suggests that this transient decay, that is not observed for RuPZn in organic
solvent, derives from the anisotropic chromophoric environment provided by the protein. As
the fully relaxed RuPZn electronically excited triplet features an extensively delocalized T1state wavefunction characterized by substantial charge-separated character,13,14,18 these
observed dynamics are congruent with the expectation that the nature of electronic
relaxation for the chromophore within the protein should not necessarily mirror that for
RuPZn in bulk solvent; in these de novo proteins, the heterogeneous dielectric protein
environment gives rise to an excited-state decay channel for unrelaxed RuPZn that is not
available in homogeneous organic solvent.
Figure 14 displays transient absorption spectral data obtained for holo-SCRPZ-1 (50 mM
phosphate buffer, 5% isopropanol, 150 mM NaCl, pH 7.5) over time delays that range
between 1 and 150 μs. Congruent with that observed for RuPZn in organic solvent, holoSCPZN-1 ground-state bleaching recovery in the B-, MLCT-, and Q-derived spectral
domains manifests uniform monoexponential dynamics. Multiwavelength analysis using a
single exponential decay model yields a 25 μs triplet lifetime for holo-SCPZN-1,
comparable to that determined for RuPZn in acetonitrile solvent (44 μs),13,14,18 indicating
that the fully relaxed electronically excited triplet states of RuPZn and holo-SCPZN-1 are
similar.
Nonlinear Optical Properties
Dynamic hyperpolarizabilities (βλ values) were determined from hyper-Rayleigh light
scattering (HRS) measurements as described previously;13,40,41 these data are summarized
in Table 1. Note that the measured values of βλ for holo-SCRPZ-1 and holo-SCRPZ-2 are
identical within experimental uncertainty, showing that the self-assembly properties of the
proteins can effectively be leveraged to construct superstructures of abiological cofactors
without affecting the inherent nonlinear optical activity of the bound chromophoric cofactor.
Modest observed differences in the magnitudes of the dynamic hyperpolarizabilities
determined for the two de novo proteins and that measured previously for RuPZn in
acetonitrile solvent derive from the facts that: (i) the βλ spectrum (the irradiation wavelength
dependent magnitude of the hyperpolarizability) depends upon both two- and three-level
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contributions (transition dipoles between ground and excited states, and transition dipoles
among excited states) and (ii) B-, Q-, and MLCT-derived transition manifolds contribute to
the measured hyperpolarizability.13,25 Theory demonstrates convincingly that the measured
magnitudes of the hyperpolarizabilities near 800 and 1300 nm for RuPZn are sensitive to
the transition energies and oscillator strengths of the B-, Q-, and MLCT-derived transition
manifolds;25 because holo-SCRPZ-1 and holo-SCRPZ-2 exhibit spectral shifts relative to
the RuPZn benchmark (note particularly that for the Q-derived states near 650 nm, Figure
5), it is thus not surprising that variations in the wavelength-dependent nonlinear response
are observed, and that small shifts in laser irradiation wavelength near 1300 nm give rise to
substantial differences in the measured dynamic hyperpolarizability (Table 1).
These data show that the designed proteins SCRPZ-1 and SCRPZ-2 are capable of binding
and orienting RuPZn, while preserving critical nonlinear optical (e.g., a large
hyperpolarizability at long wavelength) and photophysical (e.g., a microsecond timescale
triplet state lifetime) properties of the supermolecular chromophore. SCRPZ-1 and
SCRPZ-2 thus define functional scaffolds that disperse the cofactor in an aqueous
environment and protect the chromophore from detrimental aggregation effects. The protein
also provides a means to immobilize the material on a substrate, and enable engineering of
novel self-assembly motifs.
Self-Assembled Monolayers of SCRPZ-3 covalently attached to solid substrates
Using standard protocols, the C-terminus of the SCRPZ-1 protein was functionalized with a
thiol linker, -GGGC; this protein is denoted as SCRPZ-3. Like SCRPZ-1, SCRPZ-3
specifically binds RuPZn; holo-SCRPZ-3 manifests spectral characteristics identical to
holo-SCRPZ-1. Monolayers of holo-SCRPZ-3 were immobilized on a self-assembled
monolayer of 3-aminopropyldimethylethoxysilane via conjugation between the amino
functional group and the thiol of the C-terminal cysteine of SCRPZ-3 using succinimidyl-4(N-maleimidomethyl) cyclohexane-1-carboxylate (SMCC) conjugation. The linear
electronic absorption spectrum of the self-assembled holoprotein monolayer on fused silica
resembled that of holo-SCRPZ-1 (Figure 5), and not of the RuPZn chromophore in organic
solvent, consistent with the fact that RuPZn remained bound to the single chain protein,
even after immobilization of the complex on the surface of the solid substrate and
subsequent washing.
X-ray reflectivity from the covalently attached self-assembled monolayers of holo-SCRPZ-3
on GeSi multilayer substrates allowed determination of the electron density profile of the
monolayer, where interferometry was employed to phase the reflectivity data (Figure 15).
The derived profile is consistent with the long-axis of the four-helix bundle lying parallel to
the plane of the monolayer. This observed orientation for these tetra-α-helical bundle
proteins may result from the inherent flexibilities of (a) the covalent linkage between the Cterminus of the peptide and the substrate surface and (b) the GGGC terminal sequence.
Though the proteins can be affixed to the substrate at high surface densities, their
orientational order contrasts with that realized for amphiphilic helical bundles that bind
related abiological porphyrin-based chromophores,23,24,46–48 where the amphiphilic nature
of the design provided a perpendicular orientation in Langmuir monolayers at the air-water
interface at high surface pressures. However, these oligomeric, amphilic bundles were not
tailored to particular cofactors and possessed an excess of histidine residues (4) than is
necessary to bind a single chromophore/4-helix bundle via axial ligation of the PZn moiety.
By comparison, holo SCPZN-3 is a robust protein that not only provides more precise
control of the local cofactor environment but also the dispersion and processing of RuPZn in
buffer solution and its immobilization at solid interfaces.
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Conclusion
This work reports the first example of a single-chain protein computationally designed to
possess four α-helical segments and fold to encapsulate with high specificity an abiological
chromophore that exhibits exceptional nonlinear optical (NLO) properties. The single chain
109-residue tetra-α-helical bundle, SCRPZ-1, binds and disperses an insoluble
hyperpolarizable chromophore, ruthenium(II) [5-(4′-ethynyl-(2,2′;6′,2″-terpyridinyl))-10,20bis(phenyl)porphinato]zinc(II)-(2,2′;6′,2″-terpyridine)2+ (RuPZn) in aqueous buffer solution
at a 1:1 stoichiometry. Characterization data are consistent with a thermostable, highly
helical protein having a secondary structure congruent with the model tertiary structure used
to design the sequence. While SCRPZ-1 retains its helical content in the presence of the
cofactor, holo-SCRPZ-1 readily dimerizes; an empirical redesign of the protein exterior
produced a stable monomeric protein, SCRPZ-2, that also displayed a 1:1 protein:cofactor
stoichiometry.
For holo-SCRPZ-1 and holo-SCRPZ-2, in aqueous buffer, the encapsulated cofactor evinces
photophysical properties resembling those exhibited by the RuPZn cofactor in dilute organic
solvent: femtosecond-, nanosecond-, and microsecond-timescale pump-probe transient
absorption spectroscopic data evince intensely absorbing holoprotein excited states having
large spectral bandwidth that penetrate deep in the near-infrared (NIR) energy regime. The
holo-SCRPZ-1 and holo-SCRPZ-2 electronically excited triplet states exhibit microsecond
timescale lifetimes characteristic of the RuPZn chromophore. Hyper-Rayleigh light
scattering (HRS) measurements carried out at an incident irradiation wavelength (λinc) of
1340 nm for these proteins demonstrate an exceptional dynamic hyperpolarizabilty (β1340 =
3100 × 10−30 esu). Modification of the C-terminus of the protein with a GGGC extension
yields a variant, SCRPZ-3; x-ray reflectivity and linear spectroscopy establish that holoSCRPZ-3 can be immobilized on an alkyl-amine modified silicon surface in a densely
packed fashion without loss of the cofactor. Given that proteins bind and control the
conformation and orientation of cofactors, modulate their functional properties, and can
encode for protein-protein organization over mesoscopic and macroscopic length-scales,
appropriately designed de novo proteins that bind high performance abiological
chromophores promise new opportunities to control bulk-phase acentric order of NLO
functional elements and yield bio-inspired nanostructures and soft-matter materials having
unique electro-optic functionality.
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Figure 1.

Helix bundle construction: orientation of coordinating fixed histidine and stabilizing
threonine with respect to the porphyrin macrocycle.
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Figure 2.

Four-helix bundle backbone after backbone construction, top view (A); and introduction of
loops, side view (B). The interhelical distances depend on the position of the helices with
respect to the porphyrin macrocycle: helices on one side of the PZn unit (cis-porphyrin) are
closer than helices on opposite sides (trans-porphyrin). That is, the cis-porphyrin distance
CD in panel A is smaller than the trans-porphyrin distance DE.
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Figure 3.

Empirical redesign to yield SCRPZ-2: (A) details the 11 residues adopted from PASC, (B)
salt-bridge pairs, and (C) salt-bridge pairs across the hydrophobic patch.
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Figure 4.

Scheme for design of SCRPZ-1, a de novo designed protein containing the RuPZn cofactor.
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Figure 5.

Electronic absorption spectra of RuPZn in DMSO solvent (dashed line), holo-SCRPZ-1 (red
line), holo-SCRPZ-2 (blue line). Normalized at 280 nm. Lines drawn at 400, 532, 650, 670
nm are included for clarity.
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Figure 6.

Titrations of protein into a dilute cofactor solution monitored at 660 nm and the
corresponding spectra (inset): (A) SCRPZ-1 and (B) SCRPZ-2. Red lines represent fits to a
1:1 equilibrium binding model of protein and cofactor. From these data, KD (SCRPZ-1) = 32
± 1 nM, and KD (SCRPZ-2) = 1.23 ± 0.1 μM were determined.
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Figure 7.

Circular dichroism spectra of (A) SCRPZ-1 apo (black) and holo (red) and (B) SCRPZ-2
apo (black) and holo (red).
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Figure 8.

Circular dichroism spectra of the visible region of holo-SCRPZ-1 (black) and holoSCRPZ-2 (red).
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Figure 9.

Normalized ellipticity at λ = 222 nm, {[θ](T) – [θ](0 °C)}/[θ](0 °C) as a function of
temperature: (A) SCRPZ-1 apo (black) and holo (red), (B) SCRPZ-2 apo (black) and holo
(red).
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Figure 10.

Size exclusion chromatography of: (A) SCRPZ-1 apo (black line), holo (green line), and
holo + 5% iPrOH (red line), and (B) SCRPZ-2 apo (black line and holo (red line).
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Figure 11.

Analytical ultracentrifugation plots (dots) and their respective globally fitted data (solid
lines) as monitored at 20, 25, 30 kRPM (red, green, and blue respectively): (A) apoSCRPZ-1, χ2 = 3.23; (B) holo-SCRPZ-1, χ2 = 5.40; (C) apo-SCRPZ-2, χ2 = 0.503; and (D)
holo-SCRPZ-2, χ2 =2.11.
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Figure 12.

Picosecond time domain magic angle pump-probe transient absorption spectra recorded at
several time delays for holo-SCRPZ-1. Experimental conditions: ambient temperature, λex
= 660 nm; solvent, 50 mM phosphate buffer, 5% isopropanol, 150 mM NaCl, pH 7.5.
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Figure 13.

Picosecond time domain magic angle pump-probe transient absorption spectra recorded at
several time delays for holo-SCRPZ-2. Experimental conditions: ambient temperature, λex
= 660 nm; solvent, 50 mM phosphate buffer, 150 mM NaCl, pH 7.5. A scaled steady-state
absorption spectrum (inverted, red line) is displayed for comparison.
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Figure 14.

Nanosecond time domain transient absorption spectra obtained for holo-SCRPZ-1 recorded
at multiple time delays. Inset: single exponential decay profile measured at 470 nm (black
dots) with the fitted lifetime of 25 μs (solid red line). Experimental conditions: ambient
temperature, λex = 532 nm; solvent, 50 mM phosphate buffer, 5% isopropanol, 150 mM
NaCl, pH 7.5.
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Figure 15.

(A) Fresnel-normalized x-ray reflectivity from the alkylated GeSi multilayer substrate
reacted with the linker and washed (red) versus that for the same substrate with covalently
attached holo-SCRPZ-3 (blue) following washing. (B) Electron density profiles, derived
from the normalized reflectivity data via interferometry employing the GeSi multilayer as
the reference structure, where the red and blue designations are those from (a). The two
maxima from the Ge features in the GeSi multilayer appear for z < 0Å while the features of
the moist helium atmosphere appear for z > 50Å in these profiles, the wavelength of the
latter fluctuations indicative of the spatial-resolution and their amplitude of the noise-level
in the derived profiles. The inset shows the difference electron density profile due to holoSCRPZ-3 that occurs within 10Å < z < 50Å. This feature appears as a single electron
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density maximum whose FWHM is ~25Å. (C) Calculated electron density profiles for the
design target structure for holo-SCRPZ-3, assuming that the long-axis of the 4-helix bundle
is either parallel (brown) or perpendicular (green) to the plane of the self-assembled
monolayer. The former is consistent with the experimentally determined profile for holoSCRPZ-3 within these self-assembled monolayers.
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Chart 1.
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Table 1

Comparative Dynamic Hyperpolarizabilities Determined for RuPZn, Holo-SCPZN-1 and Holo-SCPZN-2 as a
Function Incident Irradiation Wavelength
βλ (10−30 esu)
Chromophore

1300 nm

1340 nm

<50

5100

Not measured

200 ± 50

1200 ± 200

3100 ± 1000

1000 ± 300

3300 ± 1000

800 nm

RuPZn13

holo-SCRPZ-1
holo-SCRPZ-2

550 ± 150

Experimental conditions: RuPZn: acetonitrile solvent, see ref13; holo-SCRPZ-1: 50 mM phosphate buffer, 5% isopropanol, 150 mM NaCl, pH
7.5; holo-SCRPZ-2: 50 mM phosphate buffer, 150 mM NaCl, pH 7.5.
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